title: Professor John M. Goldman, CML pioneer 1938-2013.
authors.affiliation: Section of Haematology, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK, rgale@celgene.com.
authors.forename: Robert Peter
authors.initials: RP
authors.lastname: Gale
mesh_terms: D000970:Antineoplastic Agents / Q000266:history* / Q000627:therapeutic use; D004739:England; D005060:Europe; D014943:Global Health / Q000266:history; D006405:Hematology / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000266:history* / Q000628:therapy; D008495:Medical Oncology / Q000266:history*; D047428:Protein Kinase Inhibitors / Q000266:history* / Q000627:therapeutic use; D012042:Registries; D012958:Societies, Scientific; D014019:Tissue Donors; D016378:Tissue Transplantation / Q000266:history*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors